Soleno Therapeutics, Inc.SLNONASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank85
3Y CAGR+68.7%
5Y CAGR+7.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+68.7%/yr
vs -10.8%/yr prior
5Y CAGR
+7.3%/yr
Recent acceleration
Acceleration
+79.5pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
2025$70.11M-20.3%
2024$87.93M-48.2%
2023$169.68M+1062.0%
2022$14.60M-31.5%
2021$21.30M-56.7%
2020$49.22M+137.4%
2019$20.73M-10.2%
2018$23.10M+35.1%
2017$17.10M+527.3%
2016$2.73M-